These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 21529634)
21. Degradation of superparamagnetic iron oxide nanoparticle-induced ferritin by lysosomal cathepsins and related immune response. Laskar A; Ghosh M; Khattak SI; Li W; Yuan XM Nanomedicine (Lond); 2012 May; 7(5):705-17. PubMed ID: 22500704 [TBL] [Abstract][Full Text] [Related]
22. Magnetic Iron Oxide Nanoparticle Labeling of Photoreceptor Precursors for Magnetic Resonance Imaging. Ma DJ; Lim MS; Park UC; Park JB; Ji SY; Yu HG Tissue Eng Part C Methods; 2019 Sep; 25(9):532-542. PubMed ID: 31418341 [TBL] [Abstract][Full Text] [Related]
23. Efficient γ-amino-proline-derived cell penetrating peptide-superparamagnetic iron oxide nanoparticle conjugates via aniline-catalyzed oxime chemistry as bimodal imaging nanoagents. Cavalli S; Carbajo D; Acosta M; Lope-Piedrafita S; Candiota AP; Arús C; Royo M; Albericio F Chem Commun (Camb); 2012 May; 48(43):5322-4. PubMed ID: 22516929 [TBL] [Abstract][Full Text] [Related]
24. Comparative in vitro and in vivo Evaluation of Different Iron Oxide-Based Contrast Agents to Promote Clinical Translation in Compliance with Patient Safety. Unterweger H; Janko C; Folk T; Cicha I; Kovács N; Gyebnár G; Horváth I; Máthé D; Zheng KH; Coolen BF; Stroes E; Szebeni J; Alexiou C; Dézsi L; Lyer S Int J Nanomedicine; 2023; 18():2071-2086. PubMed ID: 37113796 [TBL] [Abstract][Full Text] [Related]
25. Magnetic nanoparticle targeting of lysosomes: a viable method of overcoming tumor resistance? Iovino N; Bohorquez AC; Rinaldi C Nanomedicine (Lond); 2014 May; 9(7):937-9. PubMed ID: 24978459 [No Abstract] [Full Text] [Related]
26. Response to characterization of orbital masses by multiparametric MRI. Lecler A; Balvay D; Fournier L Eur J Radiol; 2016 Sep; 85(9):1686-7. PubMed ID: 27397419 [No Abstract] [Full Text] [Related]
28. Advances in nanotechnology for the treatment of GBM. Wei D; Zhang N; Qu S; Wang H; Li J Front Neurosci; 2023; 17():1180943. PubMed ID: 37214394 [TBL] [Abstract][Full Text] [Related]
31. MRI contrast enhancement potential of different superparamagnetic iron oxide nanoparticle (SPION) formulations. Schweiger C; Gil P; Parak W; Kissel T J Control Release; 2010 Nov; 148(1):e67-8. PubMed ID: 21529634 [No Abstract] [Full Text] [Related]
32. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery. Yu MK; Park J; Jeong YY; Moon WK; Jon S Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354 [TBL] [Abstract][Full Text] [Related]
33. Size-isolation of superparamagnetic iron oxide nanoparticles improves MRI, MPI and hyperthermia performance. Dadfar SM; Camozzi D; Darguzyte M; Roemhild K; Varvarà P; Metselaar J; Banala S; Straub M; Güvener N; Engelmann U; Slabu I; Buhl M; van Leusen J; Kögerler P; Hermanns-Sachweh B; Schulz V; Kiessling F; Lammers T J Nanobiotechnology; 2020 Jan; 18(1):22. PubMed ID: 31992302 [TBL] [Abstract][Full Text] [Related]
34. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Yang F; Li Y; Chen Z; Zhang Y; Wu J; Gu N Biomaterials; 2009 Aug; 30(23-24):3882-90. PubMed ID: 19395082 [TBL] [Abstract][Full Text] [Related]
36. Multifunctional polyethylenimine-conjugated superparamagnetic nanoparticles for drug delivery and imaging. Lin C; Ge J J Control Release; 2011 Nov; 152 Suppl 1():e58-60. PubMed ID: 22195926 [No Abstract] [Full Text] [Related]